-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on 10x Genomics, Raises Price Target to $68

Benzinga·11/06/2026 12:35:45
Listen to the news
Stifel analyst Daniel Arias maintains 10x Genomics (NASDAQ:TXG) with a Buy and raises the price target from $50 to $68.